Clinical Trial Update: Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis. [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety, tolerability, and preliminary efficacy of intra-articular LNA043 injections for articular cartilage lesions and knee osteoarthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• LNA043

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14